Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Ligand Pharmaceuticals Incorporated”

124 pharma patents match "Ligand Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 124
Index total 30,257
Page 5 / 6

Quick answer

This filtered view shows 124 pharmaceutical patents matching "Ligand Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

124 results for “Ligand Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 6444668

    Combination regimens using progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Sep 3, 2002 · Expires Aug 29, 2022

    expired

  2. US 6441019

    Cyclocarbamate and cyclic amide derivatives

    Ligand Pharmaceuticals Incorporated · Granted Aug 27, 2002 · Expires Aug 22, 2022

    expired

  3. US 6436929

    Cyclothiocarbamate derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Aug 20, 2002 · Expires Aug 15, 2022

    expired

  4. US 6423699

    Combination therapies using benzimidazolones

    Ligand Pharmaceuticals Incorporated · Granted Jul 23, 2002 · Expires Jul 18, 2022

    expired

  5. US 6417214

    3,3-substituted indoline derivatives

    Ligand Pharmaceuticals Incorporated · Granted Jul 9, 2002 · Expires Jul 4, 2022

    expired

  6. US 6417212

    Modulators of peroxisome proliferator activated receptors

    Ligand Pharmaceuticals Incorporated · Granted Jul 9, 2002 · Expires Jul 4, 2022

    expired

  7. US 6413952

    Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metal

    Ligand Pharmaceuticals Incorporated · Granted Jul 2, 2002 · Expires Jun 27, 2022

    expired

  8. US 6407101

    Cyanopyrroles

    Ligand Pharmaceuticals Incorporated · Granted Jun 18, 2002 · Expires Jun 13, 2022

    expired

  9. US 6399593

    Cyclic regimens using cyclic urea and cyclic amide derivatives

    Ligand Pharmaceuticals Incorporated · Granted Jun 4, 2002 · Expires May 30, 2022

    expired

  10. US 6391907

    Indoline derivatives

    Ligand Pharmaceuticals Incorporated · Granted May 21, 2002 · Expires May 16, 2022

    expired

  11. US 6380235

    Benzimidazolones and analogues

    Ligand Pharmaceuticals Incorporated · Granted Apr 30, 2002 · Expires Apr 25, 2022

    expired

  12. US 6380178

    Cyclic regimens using cyclocarbamate and cyclic amide derivatives

    Ligand Pharmaceuticals Incorporated · Granted Apr 30, 2002 · Expires Apr 25, 2022

    expired

  13. US 6380207

    Glucocortiocoid-selective antiinflammatory agents

    Ligand Pharmaceuticals Incorporated · Granted Apr 30, 2002 · Expires Apr 25, 2022

    expired

  14. US 6369056

    Cyclic urea and cyclic amide derivatives

    Ligand Pharmaceuticals Incorporated · Granted Apr 9, 2002 · Expires Apr 4, 2022

    expired

  15. US 6358947

    Tetracyclic progesterone receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Mar 19, 2002 · Expires Mar 14, 2022

    expired

  16. US 6358948

    Quinazolinone and benzoxazine derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Mar 19, 2002 · Expires Mar 14, 2022

    expired

  17. US 6355648

    Thio-oxindole derivatives

    Ligand Pharmaceuticals Incorporated · Granted Mar 12, 2002 · Expires Mar 7, 2022

    expired

  18. US 6339098

    2,1-benzisothiazoline 2,2-dioxides

    Ligand Pharmaceuticals Incorporated · Granted Jan 15, 2002 · Expires Jan 10, 2022

    expired

  19. US 6329416

    Combination regimens using 3,3-substituted indoline derivatives

    Ligand Pharmaceuticals Incorporated · Granted Dec 11, 2001 · Expires Dec 6, 2021

    expired

  20. US 6319912

    Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides

    Ligand Pharmaceuticals Incorporated · Granted Nov 20, 2001 · Expires Nov 15, 2021

    expired

  21. US 6320074

    Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors

    Ligand Pharmaceuticals Incorporated · Granted Nov 20, 2001 · Expires Nov 15, 2021

    expired

  22. US 6316404

    Treating NIDDM with RXR agonists

    Ligand Pharmaceuticals Incorporated · Granted Nov 13, 2001 · Expires Nov 8, 2021

    expired

  23. US 6306851

    Cyclocarbamate and cyclic amide derivatives

    Ligand Pharmaceuticals Incorporated · Granted Oct 23, 2001 · Expires Oct 18, 2021

    expired

  24. US 6228862

    Treating NIDDM with RXR agonists

    Ligand Pharmaceuticals Incorporated · Granted May 8, 2001 · Expires May 3, 2021

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.